Healthcare >> Analyst Interviews >> October 12, 2001

Outlook For Health Care Sectors: Geoffrey Harris – Ubs Warburg

GEOFFREY HARRIS, CFA is Head of Global Healthcare Research and Managing Director at UBS Warburg, specializing in large capitalization biotechnology companies. He was previously associated with Salomon Smith Barney and covered Managed Care and Hospital Management companies. Before that, Mr. Harris was a Senior Analyst at Tucker Anthony, Inc., and Loomis Sayles & Co. He received a BA in Economics from Oberlin College and an MA in Management Science from The Sloan School of Management at MIT. Profile
ANNABEL SAMIMY is an Associate Director in the healthcare group of UBS Warburg Equity Research. An analyst since 1999, Ms. Samimy specializes in the large capitalization biotechnology sector, with special areas of interest in monoclonal antibody technologies, cancer and autoimmune disease. Previously at UBS Warburg, Ms. Samimy worked as an Associate in the structured finance group. Ms. Samimy received her MA in International Affairs with a focus on International Finance and Business from Columbia University and a BA in International Relations from Tufts University. Profile
TWST: As head of the Healthcare Equity Research Team, what are the

coverage areas for your analysts?

Mr. Harris: We have a worldwide team that covers all of the major

sectors in health care.